U.S. Senate · 118th Congress · S. 2039
Cancer Drug Parity Act of 2023
A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Tina SmithD-MN
- Introduced
- June 15, 2023, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (21)
14 Democrats, 7 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Tammy BaldwinD-WI
- Richard BlumenthalD-CT
- Sherrod BrownD-OH
- Shelley Moore CapitoR-WV
- Cindy Hyde-SmithR-MS
- Angus S. King, Jr.D-ME
- Amy KlobucharD-MN
- Jeff MerkleyD-OR
- Jerry MoranR-KS
- Lisa MurkowskiR-AK
- Christopher MurphyD-CT
- Rick ScottR-FL
- Sheldon WhitehouseD-RI
- Roger F. WickerR-MS
Signed on later
- Dianne FeinsteinD-CASeptember 19, 2023
- Jack ReedD-RIOctober 16, 2023
- Kyrsten SinemaD-AZOctober 24, 2023
- Kevin CramerR-NDNovember 27, 2023
- Jon TesterD-MTDecember 6, 2023
- Cory A. BookerD-NJJanuary 8, 2024
- Gary C. PetersD-MIApril 30, 2024